期刊
BRAIN BEHAVIOR AND IMMUNITY
卷 19, 期 1, 页码 23-27出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2004.05.001
关键词
interferon-alpha; ribavirin; hepatitis C; gastroenterology; mood disorders; depression; cytokines; viral genotype; viral load
资金
- NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060723, K23MH064619] Funding Source: NIH RePORTER
- NIMH NIH HHS [MH00680, MH60723, MH64619, R01 MH060723-04] Funding Source: Medline
Interferon (IFN)-alpha plus ribavirin is an effective treatment for hepatitis C virus (HCV) infection, but is associated with a high rate of depression. Depression has been linked to a worse outcome in multiple medical disorders including viral illnesses. We examined whether increased symptoms of depression during IFN-alpha/ribavirin therapy were associated with a reduced treatment response as assessed by clearance of HCV. Depressive symptoms were evaluated in 102 HCV-infected patients at baseline and after 4. 8. 12. and 24 weeks of pegylated IFN-alpha-2b plus ribavirin therapy using the Zung self-rating depression scale (SDS). Viral clearance was determined at 24 weeks by polymerase chain reaction (PCR). Only 34% of subjects (10 out of 29) with a 20-point or greater increase in SDS Index score were HCV PCR negative at 24 weeks, compared to 59% (24 out of 41) of patients with a 10-19 point increase in SDS Index and 69% (22 out of 32) of patients with a less than 10 point increase (chi(2) = 7.6, df = 2. p < 0.0-5). In addition, a 20 point or greater increase in SDS Index score during IFN-alpha/ribavirin therapy significantly predicted failure to clear virus when considered alone [crude odds ratio (OR), 3.2-95% confidence interval (CI), 1.3-8.0; p < 0.01] or when controlling for other factors that affected IFN-alpha treatment response (adjusted OR, 3.6-95% CI, 1.3-9.5; p = 0.01). These preliminary finding suggest that individuals who experience significant increases in depressive symptoms during IFN-a/ribavirin therapy may be less likely to clear virus, highlighting the importance of identifying and treating depressive symptoms in this patient population. (C) 2004 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据